Xiaojiang Duan

839 total citations
51 papers, 644 citations indexed

About

Xiaojiang Duan is a scholar working on Radiology, Nuclear Medicine and Imaging, Pulmonary and Respiratory Medicine and Oncology. According to data from OpenAlex, Xiaojiang Duan has authored 51 papers receiving a total of 644 indexed citations (citations by other indexed papers that have themselves been cited), including 28 papers in Radiology, Nuclear Medicine and Imaging, 25 papers in Pulmonary and Respiratory Medicine and 19 papers in Oncology. Recurrent topics in Xiaojiang Duan's work include Radiopharmaceutical Chemistry and Applications (24 papers), Peptidase Inhibition and Analysis (16 papers) and Prostate Cancer Treatment and Research (12 papers). Xiaojiang Duan is often cited by papers focused on Radiopharmaceutical Chemistry and Applications (24 papers), Peptidase Inhibition and Analysis (16 papers) and Prostate Cancer Treatment and Research (12 papers). Xiaojiang Duan collaborates with scholars based in China, United States and South Korea. Xiaojiang Duan's co-authors include Xing Yang, Junbo Zhang, Qing Ruan, Xuran Zhang, Zhi Yang, Martin G. Pomper, Jianjun Wang, Jingming Zhang, Wu Wangsuo and Ning Zhang and has published in prestigious journals such as Nature Communications, SHILAP Revista de lepidopterología and Clinical Cancer Research.

In The Last Decade

Xiaojiang Duan

48 papers receiving 637 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Xiaojiang Duan China 16 249 175 163 158 129 51 644
Guoqiang Shao China 18 248 1.0× 206 1.2× 182 1.1× 234 1.5× 254 2.0× 71 888
Ken Kersemans Belgium 15 215 0.9× 119 0.7× 135 0.8× 169 1.1× 78 0.6× 48 600
Anatoly N. Pinchuk United States 10 155 0.6× 116 0.7× 125 0.8× 196 1.2× 314 2.4× 20 765
Martin Ullrich Germany 17 185 0.7× 167 1.0× 67 0.4× 248 1.6× 97 0.8× 55 835
Mohit S. Kasibhatla United States 9 70 0.3× 108 0.6× 179 1.1× 252 1.6× 220 1.7× 18 744
Steffi Koerner United States 10 213 0.9× 52 0.3× 105 0.6× 197 1.2× 53 0.4× 12 731
Zizhuo Zhao China 18 105 0.4× 238 1.4× 69 0.4× 194 1.2× 268 2.1× 34 869
Júlia Baguña Torres United Kingdom 14 209 0.8× 218 1.2× 85 0.5× 141 0.9× 95 0.7× 27 633

Countries citing papers authored by Xiaojiang Duan

Since Specialization
Citations

This map shows the geographic impact of Xiaojiang Duan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaojiang Duan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaojiang Duan more than expected).

Fields of papers citing papers by Xiaojiang Duan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xiaojiang Duan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaojiang Duan. The network helps show where Xiaojiang Duan may publish in the future.

Co-authorship network of co-authors of Xiaojiang Duan

This figure shows the co-authorship network connecting the top 25 collaborators of Xiaojiang Duan. A scholar is included among the top collaborators of Xiaojiang Duan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xiaojiang Duan. Xiaojiang Duan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Chen, Xueqi, et al.. (2025). Noninvasive Evaluation of HER2 Expression and Heterogeneity in Urothelial Carcinoma on 68Ga-HER2-affibody PET/CT. Clinical Nuclear Medicine. 51(2). 99–107.
2.
Yin, Lei, Xiaojiang Duan, Zhijian Fu, et al.. (2025). HER2-targeted PET/CT imaging provides potential biomarkers for differentiating HER2-zero, -low, and -positive breast cancer. European Journal of Nuclear Medicine and Molecular Imaging. 52(12). 4525–4538. 2 indexed citations
3.
Zhang, Jianhua, Xiaojiang Duan, Xueqi Chen, et al.. (2024). Translational PET Imaging of Nectin-4 Expression in Multiple Different Cancers with68Ga-N188. Journal of Nuclear Medicine. 65(Supplement 1). 12S–18S. 18 indexed citations
4.
Duan, Xiaojiang, et al.. (2024). Synthesis and Evaluation of 99mTc-Labeled l-Aspartic Acid as a EuK Polymer Linker for Targeting PSMA to a Novel SPECT Tumor Tracer. Journal of Medicinal Chemistry. 67(23). 21617–21628. 2 indexed citations
5.
6.
Wang, Haiyan, et al.. (2024). Supplemental n-3 polyunsaturated fatty acids: Clinical implications and best practices for adult patients with cancer. SHILAP Revista de lepidopterología. 10(1). 1–7.
7.
Yi, Tieci, Difei Lu, Yonggang Cui, et al.. (2024). 68Ga-pentixafor PET/CT Is a Supplementary Method for Primary Aldosteronism Subtyping Compared with Adrenal Vein Sampling. Molecular Imaging and Biology. 27(1). 142–150. 3 indexed citations
8.
Duan, Xiaojiang, Lei Xia, Martin G. Pomper, et al.. (2023). First-in-Human Study of the Radioligand 68Ga-N188 Targeting Nectin-4 for PET/CT Imaging of Advanced Urothelial Carcinoma. Clinical Cancer Research. 29(17). 3395–3407. 56 indexed citations
9.
Duan, Xiaojiang, et al.. (2023). Synthesis and characterization of a novel 68Ga-labeled p-bromobenzyl lysine-urea-ODAP PSMA inhibitor. Bioorganic & Medicinal Chemistry Letters. 91. 129382–129382. 1 indexed citations
10.
Wang, Yong, Jingming Zhang, Boyang Han, et al.. (2023). Noncanonical amino acids as doubly bio-orthogonal handles for one-pot preparation of protein multiconjugates. Nature Communications. 14(1). 974–974. 42 indexed citations
11.
Liu, Chen, Teli Liu, Xiaojiang Duan, et al.. (2022). Preclinical evaluation and first in human study of Al18F radiolabeled ODAP-urea-based PSMA targeting ligand for PET imaging of prostate cancer. Frontiers in Oncology. 12. 1030187–1030187. 6 indexed citations
12.
Chen, Zhao, Xiaojiang Duan, Ping Yan, et al.. (2022). 99mTc-labeled peptide targeting interleukin 13 receptor α 2 for tumor imaging in a cervical cancer mouse model. Annals of Nuclear Medicine. 36(4). 360–372. 4 indexed citations
13.
Yan, Ping, Chunli Zhang, Xiaojiang Duan, et al.. (2021). Arginine–Arginine–Leucine Peptide Targeting Heat Shock Protein 70 for Cancer Imaging. Molecular Pharmaceutics. 18(10). 3750–3762. 1 indexed citations
14.
Zhang, Jingming, Xiaojiang Duan, Qingqing Yin, et al.. (2021). A prostate-specific membrane antigen activated molecular rotor for real-time fluorescence imaging. Nature Communications. 12(1). 5460–5460. 55 indexed citations
15.
16.
Zhang, Xiaoying, et al.. (2019). Local and systemic delivery of mRNA encoding survivin-T34A by lipoplex for efficient colon cancer gene therapy. SHILAP Revista de lepidopterología. 1 indexed citations
17.
Zhang, Xuran, Qing Ruan, Xiaojiang Duan, et al.. (2018). Novel 99mTc-Labeled Glucose Derivative for Single Photon Emission Computed Tomography: A Promising Tumor Imaging Agent. Molecular Pharmaceutics. 15(8). 3417–3424. 33 indexed citations
18.
Duan, Xiaojiang, Teli Liu, Yichun Zhang, & Junbo Zhang. (2016). Synthesis and Biological Evaluation of Novel 99mTc(CO)3-Labeled Thymidine Analogs as Potential Probes for Tumor Proliferation Imaging. Molecules. 21(4). 510–510. 8 indexed citations
19.
Fang, Rui, Qi Cui, Jun Sun, et al.. (2015). PDK1/Akt/PDE4D axis identified as a target for asthma remedy synergistic with β2ARagonists by a natural agent arctigenin. Allergy. 70(12). 1622–1632. 28 indexed citations
20.
Dong, Feng, Jing Yang, Xiaojiang Duan, et al.. (2010). Synthesis and preliminary biodistribution studies of [131I]SIB-PEG4-CHC in tumor-bearing mice. Journal of Radioanalytical and Nuclear Chemistry. 287(1). 113–117. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Guoqiang Shao Breakdown of academic impact, for papers by Ken Kersemans Breakdown of academic impact, for papers by Anatoly N. Pinchuk Breakdown of academic impact, for papers by Martin Ullrich Breakdown of academic impact, for papers by Mohit S. Kasibhatla Breakdown of academic impact, for papers by Steffi Koerner Breakdown of academic impact, for papers by Zizhuo Zhao Breakdown of academic impact, for papers by Júlia Baguña Torres
Rankless by CCL
2026